114 related articles for article (PubMed ID: 23289464)
1. The outcome of tuberculosis cases with persistent smear positivity at the end of extended initial phase.
Babalık A; Calışır H; Bakırcı N; Arda H; Kızıltaş Ş; Oruç K; Çetintaş G
Tuberk Toraks; 2012; 60(4):344-9. PubMed ID: 23289464
[TBL] [Abstract][Full Text] [Related]
2. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
Tiwari S; Kumar A; Kapoor SK
Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
[TBL] [Abstract][Full Text] [Related]
3. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
6. Association of conversion & cure with initial smear grading among new smear positive pulmonary tuberculosis patients treated with Category I regimen.
Gopi PG; Chandrasekaran V; Subramani R; Santha T; Thomas A; Selvakumar N; Narayanan PR
Indian J Med Res; 2006 Jun; 123(6):807-14. PubMed ID: 16885603
[TBL] [Abstract][Full Text] [Related]
7. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
Parikh R; Nataraj G; Kanade S; Khatri V; Mehta P
J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting sputum smear conversion and treatment outcomes in new smear-positive pulmonary tuberculosis.
Unsematham S; Kateruttanakul P
J Med Assoc Thai; 2013 Jun; 96(6):644-9. PubMed ID: 23951819
[TBL] [Abstract][Full Text] [Related]
10. Profile and treatment outcome of smear-positive TB patients who failed to smear convert after 2 months of treatment in Nigeria.
Ukwaja KN; Oshi DC; Oshi SN; Alobu I
Trans R Soc Trop Med Hyg; 2014 Jul; 108(7):431-8. PubMed ID: 24846911
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of different subgroups of smear-positive retreatment patients under RNTCP in rural West Bengal, India.
Mukherjee A; Sarkar A; Saha I; Biswas B; Bhattacharyya PS
Rural Remote Health; 2009; 9(1):926. PubMed ID: 19260766
[TBL] [Abstract][Full Text] [Related]
12. The rates of sputum conversion among new smear positive open pulmonary tuberculosis patients treated under directly observed treatment, short course strategy.
Chaudhry LA; Al-Shamri AS; Ba Essa EM; Robert AA; Al-Solaiman S; Al-Nwasser AH
Saudi Med J; 2014 Jan; 35(1):39-43. PubMed ID: 24445888
[TBL] [Abstract][Full Text] [Related]
13. Yield of continued monthly sputum evaluation among tuberculosis patients after culture conversion.
Sundaram V; Fujiwara PI; Driver CR; Osahan SS; Munsiff SS
Int J Tuberc Lung Dis; 2002 Mar; 6(3):238-45. PubMed ID: 11934142
[TBL] [Abstract][Full Text] [Related]
14. [Clinical, epidemiological and microbiological characteristics of a cohort of pulmonary tuberculosis patients in Cali, Colombia].
Rojas CM; Villegas SL; Piñeros HM; Chamorro EM; Durán CE; Hernández EL; Pacheco R; Ferro BE
Biomedica; 2010; 30(4):482-91. PubMed ID: 21713351
[TBL] [Abstract][Full Text] [Related]
15. Implementation of the DOTS strategy for tuberculosis in the Leningrad Region, Russian Federation (1998-1999).
Ruohonen RP; Goloubeva TM; Trnka L; Fomin MM; Zhemkova GA; Sinitsyn AV; Lichachev AA; Koskela KG
Int J Tuberc Lung Dis; 2002 Mar; 6(3):192-7. PubMed ID: 11934136
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis control in Bangladesh: success of the DOTS strategy.
Kumaresan JA; Ahsan Ali AK; Parkkali LM
Int J Tuberc Lung Dis; 1998 Dec; 2(12):992-8. PubMed ID: 9869115
[TBL] [Abstract][Full Text] [Related]
17. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in The Gambia.
Lienhardt C; Manneh K; Bouchier V; Lahai G; Milligan PJ; McAdam KP
Int J Tuberc Lung Dis; 1998 Sep; 2(9):712-8. PubMed ID: 9755924
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of pulmonary tuberculosis in a low-prevalence urban area. Compliance and sputum conversion].
Stoffel C; Lorenz R; Arce M; Rico M; Fernández L; Imaz MS
Medicina (B Aires); 2014; 74(1):9-18. PubMed ID: 24561834
[TBL] [Abstract][Full Text] [Related]
19. Sputum microscopy results at two and three months predict outcome of tuberculosis treatment.
Zhao FZ; Levy MH; Wen S
Int J Tuberc Lung Dis; 1997 Dec; 1(6):570-2. PubMed ID: 9487456
[TBL] [Abstract][Full Text] [Related]
20. Decentralisation of treatment for patients with tuberculosis in Malawi: moving from research to policy and practice.
Salaniponi FM; Gausi F; Mphasa N; Nyirenda TE; Kwanjana JH; Harries AD
Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S38-47. PubMed ID: 12971653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]